Full Text View
Tabular View
No Study Results Posted
Related Studies
RICE Trial: Rifaximin In Chronic Hepatic Encephalopathy - A Randomized, Controlled Trial
This study is currently recruiting participants.
Study NCT00364689   Information provided by University of Miami
First Received: August 15, 2006   Last Updated: April 26, 2007   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Hepatic Encephalopathy
Additional conditions recognized in this trial
Brain Damage, Chronic
Delirium
Encephalitis
Neurotoxicity Syndromes
More general conditions related to this trial
Brain Diseases
Brain Diseases, Metabolic
Central Nervous System Diseases
Central Nervous System Infections
Central Nervous System Viral Diseases
Confusion
Delirium, Dementia, Amnestic, Cognitive Disorders
Digestive System Diseases
Disorders of Environmental Origin
Hepatic Insufficiency
Liver Diseases
Liver Failure
Mental Disorders
Metabolic Diseases
Nervous System Diseases
Neurobehavioral Manifestations
Neurologic Manifestations
Poisoning
Signs and Symptoms
Virus Diseases
Additional drug interventions recognized in this trial
Rifaximin
More general drug interventions related to this trial
Anti-Infective Agents
Gastrointestinal Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of Miami
Salix Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services